Published in Eur Radiol on June 20, 2010
Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2013) 1.50
Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging (2012) 1.08
Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol (2013) 1.07
Liver diffusion-weighted MR imaging: the tower of Babel? Eur Radiol (2010) 1.05
Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. Br J Radiol (2011) 0.97
Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI. World J Hepatol (2014) 0.96
MRI of Focal Liver Lesions. Curr Med Imaging Rev (2012) 0.93
Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. PLoS One (2012) 0.86
Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT. Eur Radiol (2011) 0.84
MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid. Korean J Radiol (2013) 0.84
Staging of colorectal liver metastases after preoperative chemotherapy. Diffusion-weighted imaging in combination with Gd-EOB-DTPA MRI sequences increases sensitivity and diagnostic accuracy. Eur Radiol (2012) 0.83
Diffusion-weighted imaging of the liver: an update. Cancer Imaging (2013) 0.82
The impact of hepatocyte phase imaging from infancy to young adulthood in patients with a known or suspected liver lesion. Pediatr Radiol (2014) 0.80
A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. Eur Radiol (2016) 0.79
Diffusion-weighted MRI for detecting liver metastases: importance of the b-value. Eur Radiol (2010) 0.77
FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION. Arq Bras Cir Dig (2015) 0.76
Diffusion-weighted imaging of the liver: techniques and applications. Magn Reson Imaging Clin N Am (2014) 0.76
Morphologic and Functional Imaging of Non-Colorectal Liver Metastases. Viszeralmedizin (2015) 0.75
The efficacy of diffusion weighted imaging and apparent diffusion coefficients mapping for liver metastasis of colonic adenocarcinomas. Saudi Med J (2016) 0.75
Diffusion-weighted imaging of the liver: Current applications. World J Radiol (2016) 0.75
Systemic treatment in breast cancer: a primer for radiologists. Insights Imaging (2015) 0.75
Diffusion-weighted imaging of pancreatic cancer. World J Radiol (2015) 0.75
Use of contrast agents in oncological imaging: magnetic resonance imaging. Cancer Imaging (2013) 0.75
Detection of liver metastases in cancer patients with geographic fatty infiltration of the liver: the added value of contrast-enhanced sonography. Ultrasonography (2017) 0.75
Added value of arterial enhancement fraction color maps for the characterization of small hepatic low-attenuating lesions in patients with colorectal cancer. PLoS One (2015) 0.75
Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon's Perspective! Int J Hepatol (2013) 0.75
Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomen. Eur Radiol (2013) 0.75
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA (2000) 13.68
Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics (2001) 3.34
Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology (1995) 2.38
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology (1996) 1.86
Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology (2004) 1.82
Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol (1998) 1.80
Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology (1996) 1.74
MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci (2007) 1.71
CT and MR imaging of benign hepatic and biliary tumors. Radiographics (1999) 1.71
Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology (2005) 1.44
RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline. Eur Radiol (2009) 1.44
Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology (2006) 1.41
Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging (2007) 1.24
Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol (2003) 1.13
Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol (2009) 1.08
Diffusion-weighted images of the liver: comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide. J Magn Reson Imaging (2005) 1.04
Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging (2009) 0.98
Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model. J Comput Assist Tomogr (2009) 0.93
Benign liver tumors. Magn Reson Imaging Clin N Am (1997) 0.93
Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology (2001) 0.93
Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology (2006) 0.83
MR imaging of hepatic metastases. Magn Reson Imaging Clin N Am (2002) 0.80
3T MR for clinical use: update. Magn Reson Med Sci (2003) 0.80
[Modern visualization of the liver with MRT. Current trends and future perspectives]. Radiologe (2004) 0.75
Thyroid gland tumor diagnosis at US elastography. Radiology (2005) 3.26
Cervical lymph node metastases: diagnosis at sonoelastography--initial experience. Radiology (2007) 2.56
Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet (2005) 2.39
Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol (2009) 2.23
Radiologic manifestations of sarcoidosis in various organs. Radiographics (2004) 2.04
Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol (2005) 1.97
Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology (2009) 1.86
MR features of ectopic pregnancy. Eur Radiol (2007) 1.53
The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol (2007) 1.50
Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases. J Nucl Med (2011) 1.45
Pictorial review of tuberous sclerosis in various organs. Radiographics (2008) 1.43
Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography. Int J Cardiovasc Imaging (2007) 1.39
Biliary reconstruction in right lobe living-donor liver transplantation: Comparison of different techniques in 321 recipients. Ann Surg (2006) 1.35
Successful islet transplantation from nonheartbeating donor pancreata using modified Ricordi islet isolation method. Transplantation (2006) 1.26
F-18 FDG PET of foreign body granuloma: pathologic correlation with imaging features in 3 cases. Clin Nucl Med (2010) 1.25
MR imaging findings of adenomyosis: correlation with histopathologic features and diagnostic pitfalls. Radiographics (2005) 1.23
Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging (2007) 1.20
Clinical performance of 2 dedicated PET scanners for breast imaging: initial evaluation. J Nucl Med (2012) 1.17
Temporal change in human nicotinic acetylcholine receptor after smoking cessation: 5IA SPECT study. J Nucl Med (2007) 1.17
High 18F-fluorodeoxyglocose uptake in adrenal histoplasmosis; a case report. Eur Radiol (2005) 1.12
Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer. Radiother Oncol (2010) 1.12
Percutaneous transhepatic balloon dilation of portal venous stenosis in patients with living donor liver transplantation. Radiology (2005) 1.11
MRI artifact reduction and quality improvement in the upper abdomen with PROPELLER and prospective acquisition correction (PACE) technique. AJR Am J Roentgenol (2008) 1.11
Evaluation of primary brain tumors with FLT-PET: usefulness and limitations. Clin Nucl Med (2006) 1.10
Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer. Cancer Invest (2007) 1.09
Estimation of global and regional cardiac function using 64-slice computed tomography: a comparison study with echocardiography, gated-SPECT and cardiovascular magnetic resonance. Int J Cardiol (2007) 1.07
Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma. Cancer (2010) 1.07
Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation. Invest Radiol (2012) 1.05
Diffusely enlarged uterus: evaluation with MR imaging. Radiographics (2003) 1.04
Development and evaluation of a low-cost and high-capacity DICOM image data storage system for research. J Digit Imaging (2010) 1.03
Outcome of percutaneous transhepatic venoplasty for hepatic venous outflow obstruction after living donor liver transplantation. Radiology (2006) 1.03
Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation. Abdom Imaging (2007) 1.03
CT and MR features of struma ovarii. Abdom Imaging (2012) 1.02
Prenatal differential diagnosis of complete hydatidiform mole with a twin live fetus and placental mesenchymal dysplasia by magnetic resonance imaging. J Obstet Gynaecol Res (2014) 1.01
Functional MR imaging of the female pelvis. J Magn Reson Imaging (2007) 1.01
Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study. Radiology (2011) 1.00
Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome. J Vasc Interv Radiol (2004) 1.00
Evaluation of motion correction effect and image quality with the periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) (BLADE) and parallel imaging acquisition technique in the upper abdomen. J Magn Reson Imaging (2008) 0.99
Quantitative non-Gaussian diffusion and intravoxel incoherent motion magnetic resonance imaging: differentiation of malignant and benign breast lesions. Invest Radiol (2015) 0.99
Non-contrast-enhanced MR angiography of the abdomen. Eur J Radiol (2011) 0.99
MRCP imaging at 3.0 T vs. 1.5 T: preliminary experience in healthy volunteers. J Magn Reson Imaging (2007) 0.99
The potential clinical value of FDG-PET for recurrent renal cell carcinoma. Eur J Radiol (2009) 0.98
Immature teratoma of the ovary: correlation of MR imaging and pathologic findings. Eur Radiol (2002) 0.98
Clinical value of ¹¹C-methionine PET/CT in patients with plasma cell malignancy: comparison with ¹⁸F-FDG PET/CT. Eur J Nucl Med Mol Imaging (2013) 0.98
Spectrum of MR features in adenomyosis. Best Pract Res Clin Obstet Gynaecol (2006) 0.97
Corticospinal tract localization: integration of diffusion-tensor tractography at 3-T MR imaging with intraoperative white matter stimulation mapping--preliminary results. Radiology (2006) 0.96
Contrast-enhanced volumetric interpolated breath-hold examination compared with spin-echo T1-weighted imaging of head and neck tumors. AJR Am J Roentgenol (2005) 0.96
Vascular dilatation in the pelvis: identification with CT and MR imaging. Radiographics (2004) 0.96
Posterior cul-de-sac obliteration associated with endometriosis: MR imaging evaluation. Radiology (2005) 0.96
Non-contrast-enhanced hepatic MR angiography with true steady-state free-precession and time spatial labeling inversion pulse: optimization of the technique and preliminary results. Eur J Radiol (2008) 0.95
Gray matter-white matter contrast on spin-echo T1-weighted images at 3 T and 1.5 T: a quantitative comparison study. Eur Radiol (2007) 0.94
Microbleeds in moyamoya disease: susceptibility-weighted imaging versus T2*-weighted imaging at 3 Tesla. Invest Radiol (2008) 0.94
Diffusion-tensor fiber tractography: intraindividual comparison of 3.0-T and 1.5-T MR imaging. Radiology (2006) 0.94
Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based magnetic resonance contrast agent. Kidney Int (2002) 0.94
A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia. Nucl Med Commun (2015) 0.94
A case of struma uteri. AJR Am J Roentgenol (2005) 0.94
Comparison of 3.0- and 1.5-T three-dimensional time-of-flight MR angiography in moyamoya disease: preliminary experience. Radiology (2006) 0.94
Relationship between 18F-fluorodeoxyglucose accumulation and KRAS/BRAF mutations in colorectal cancer. Clin Cancer Res (2012) 0.93
Organizing intracerebral hematoma mimicking a recurrent brain tumor on FDG-PET. Clin Nucl Med (2013) 0.92
Factors influencing liver regeneration following living-donor liver transplantation of the right hepatic lobe. Transplantation (2003) 0.92
Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer. J Thorac Oncol (2015) 0.92
Esophageal cancer: evaluation with triple-phase dynamic CT--initial experience. Radiology (2006) 0.91
Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology (2006) 0.91
Hepatic venous outflow obstruction in pediatric living donor liver transplantation using left-sided lobe grafts: Kyoto University experience. Liver Transpl (2010) 0.91
Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar. AJR Am J Roentgenol (2002) 0.91
Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET. Ann Nucl Med (2006) 0.90
MR features of physiologic and benign conditions of the ovary. Eur Radiol (2006) 0.90
Clinical value of whole-body FDG-PET for recurrent gastric cancer: a multicenter study. Jpn J Clin Oncol (2009) 0.90
Association between polyclonal and mixed mycobacterial Mycobacterium avium complex infection and environmental exposure. Ann Am Thorac Soc (2014) 0.90
Non-contrast-enhanced MR portography with time-spatial labeling inversion pulses: comparison of imaging with three-dimensional half-fourier fast spin-echo and true steady-state free-precession sequences. J Magn Reson Imaging (2009) 0.89
Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease. J Nucl Med (2007) 0.89
Fat-water interface on susceptibility-weighted imaging and gradient-echo imaging: comparison of phantoms to intracranial lipomas. AJR Am J Roentgenol (2013) 0.89
MRI of the female pelvis at 3T compared to 1.5T: evaluation on high-resolution T2-weighted and HASTE images. J Magn Reson Imaging (2007) 0.89
High spatial resolution 3D MR cholangiography with high sampling efficiency technique (SPACE): comparison of 3T vs. 1.5T. Eur J Radiol (2008) 0.89
FDG-PET/CT assessment of misty mesentery: feasibility for distinguishing viable mesenteric malignancy from stable conditions. Eur J Radiol (2013) 0.88
Grading glial tumors with amide proton transfer MR imaging: different analytical approaches. J Neurooncol (2015) 0.88
Coronary angiography by 64-detector row computed tomography using low dose of contrast material with saline chaser: influence of total injection volume on vessel attenuation. J Comput Assist Tomogr (2007) 0.88